Working… Menu
Trial record 4 of 524 for:    melanoma phase III

HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03435302
Recruitment Status : Recruiting
First Posted : February 16, 2018
Last Update Posted : February 16, 2018
Information provided by (Responsible Party):
Lu Si, Beijing Cancer Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2018
Estimated Study Completion Date : February 2019